NOS3 and type 2 diabetes mellitus: The observed sex difference also suggest that more aggressive or pre-emptive pharmacological treatment with commonly used drugs that promote eNOS activity or NO bioavailability (statins, angiotensinogen inhibitors, AT-1 blockers, folate, antioxidants) [2,8,42] could be considered in women with T2DM.